Altre lingue Nexien BioPharma, Inc.

Azioni

NXEN

US65343D1000

Mercato chiuso - OTC Markets Altri mercati azionari 16:57:41 05/07/2024			Variaz. 5gg	Var. 1 gen.
0,0274 ^USD	+10,93%		+62,13%	+5,79%

15/05	Nexien BioPharma, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 marzo 2024	CI
20/02	Nexien BioPharma, Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Nexien BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	15/05
Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	20/02
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	14/11
Nexien BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	28/09/23
Nexien BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	17/05/23
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	08/02/23
Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	08/02/23
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	09/11/22
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	09/11/22
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	28/09/22
Nexien BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	28/09/22
Nexien BioPharma, Inc. Auditor Raises 'Going Concern' Doubt	28/09/22
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	12/05/22
Nexien BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	12/05/22
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	08/02/22
Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	08/02/22
NEXIEN BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	21/01/22
Nexien BioPharma, Inc. announced that it has received $0.15 million in funding from Quick Capital, LLC	18/01/22
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	22/11/21
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	22/11/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Nexien BioPharma, Inc.

Azioni

NXEN

US65343D1000

Altre lingue

Filtri